BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25665575)

  • 1. Models of protein-ligand crystal structures: trust, but verify.
    Deller MC; Rupp B
    J Comput Aided Mol Des; 2015 Sep; 29(9):817-36. PubMed ID: 25665575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Protein-Ligand Crystal Structure Models: Small Molecule and Peptide Ligands.
    Pozharski E; Deller MC; Rupp B
    Methods Mol Biol; 2017; 1607():611-625. PubMed ID: 28573591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank.
    Yang H; Guranovic V; Dutta S; Feng Z; Berman HM; Westbrook JD
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1833-9. PubMed ID: 15388930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating protein structures determined by structural genomics consortia.
    Bhattacharya A; Tejero R; Montelione GT
    Proteins; 2007 Mar; 66(4):778-95. PubMed ID: 17186527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ligands in macromolecular structures determined by X-ray crystallography.
    Smart OS; Horský V; Gore S; Svobodová Vařeková R; Bendová V; Kleywegt GJ; Velankar S
    Acta Crystallogr D Struct Biol; 2018 Mar; 74(Pt 3):228-236. PubMed ID: 29533230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. You are lost without a map: Navigating the sea of protein structures.
    Lamb AL; Kappock TJ; Silvaggi NR
    Biochim Biophys Acta; 2015 Apr; 1854(4):258-68. PubMed ID: 25554228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new test set for validating predictions of protein-ligand interaction.
    Nissink JW; Murray C; Hartshorn M; Verdonk ML; Cole JC; Taylor R
    Proteins; 2002 Dec; 49(4):457-71. PubMed ID: 12402356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure.
    Borbulevych O; Martin RI; Westerhoff LM
    Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of automatic ligand building in ARP/wARP.
    Evrard GX; Langer GG; Perrakis A; Lamzin VS
    Acta Crystallogr D Biol Crystallogr; 2007 Jan; 63(Pt 1):108-17. PubMed ID: 17164533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques, tools and best practices for ligand electron-density analysis and results from their application to deposited crystal structures.
    Pozharski E; Weichenberger CX; Rupp B
    Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):150-67. PubMed ID: 23385452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray crystallography in drug discovery.
    Carvalho AL; Trincão J; Romão MJ
    Methods Mol Biol; 2009; 572():31-56. PubMed ID: 20694684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational tools for the analysis and visualization of multiple protein-ligand complexes.
    O'Brien SE; Brown DG; Mills JE; Phillips C; Morris G
    J Mol Graph Model; 2005 Dec; 24(3):186-94. PubMed ID: 16169759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse, high-quality test set for the validation of protein-ligand docking performance.
    Hartshorn MJ; Verdonk ML; Chessari G; Brewerton SC; Mooij WT; Mortenson PN; Murray CW
    J Med Chem; 2007 Feb; 50(4):726-41. PubMed ID: 17300160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tools for ligand validation in Coot.
    Emsley P
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):203-210. PubMed ID: 28291755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design.
    Borbulevych OY; Martin RI; Westerhoff LM
    J Comput Aided Mol Des; 2021 Apr; 35(4):433-451. PubMed ID: 33108589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop.
    Adams PD; Aertgeerts K; Bauer C; Bell JA; Berman HM; Bhat TN; Blaney JM; Bolton E; Bricogne G; Brown D; Burley SK; Case DA; Clark KL; Darden T; Emsley P; Feher VA; Feng Z; Groom CR; Harris SF; Hendle J; Holder T; Joachimiak A; Kleywegt GJ; Krojer T; Marcotrigiano J; Mark AE; Markley JL; Miller M; Minor W; Montelione GT; Murshudov G; Nakagawa A; Nakamura H; Nicholls A; Nicklaus M; Nolte RT; Padyana AK; Peishoff CE; Pieniazek S; Read RJ; Shao C; Sheriff S; Smart O; Soisson S; Spurlino J; Stouch T; Svobodova R; Tempel W; Terwilliger TC; Tronrud D; Velankar S; Ward SC; Warren GL; Westbrook JD; Williams P; Yang H; Young J
    Structure; 2016 Apr; 24(4):502-508. PubMed ID: 27050687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and refinement of model protein-ligand complexes.
    Orry AJ; Abagyan R
    Methods Mol Biol; 2012; 857():351-73. PubMed ID: 22323230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation.
    Brylinski M; Skolnick J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):129-34. PubMed ID: 18165317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational resources for protein modelling and drug discovery applications.
    Dhaliwal B; Chen YW
    Infect Disord Drug Targets; 2009 Nov; 9(5):557-62. PubMed ID: 19594423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated protein-ligand crystallography for structure-based drug design.
    Mooij WT; Hartshorn MJ; Tickle IJ; Sharff AJ; Verdonk ML; Jhoti H
    ChemMedChem; 2006 Aug; 1(8):827-38. PubMed ID: 16902937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.